Erman Akkus/X
Dec 24, 2024, 11:09
Erman Akkus: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma
Erman Akkus, Medical Oncology fellow at Ankara University, shared a poston X:
“Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma.
- Acquired resistance: via secondary FGFR2 mutations in >60% of patients with clinical benefit
- low achievable drug concentrations in humans >emergence of resistance
- FGFR inhibitors should be small, high-affinity, selective
- Tinengotinib.”
More posts featuring Erman Akkus.
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 24, 2024, 12:28
Dec 24, 2024, 12:16
Dec 24, 2024, 12:09
Dec 24, 2024, 11:44
Dec 24, 2024, 11:28
Dec 24, 2024, 11:09